Author

Manal Elmasry

Stony Brook MedicinePrimary ORCID profile (0000-0001-8125-5790 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Manal ElmasryiD1 paper · Mansoura University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chiara LubertoiD· 1 shared Guoying YuiD· 1 shared Sam B Chiappone· 1 shared Suhu Liu· 1 shared Yasharah RazaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chiara LubertoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Fenretinide targets GATA1 to induce cytotoxicity in GATA1 positive Acute Erythroid and Acute Megakaryoblastic Leukemic cells.

Yasharah Raza, Manal Elmasry, Guoying Yu, Sam B Chiappone, Suhu Liu, Chiara Luberto

This paper identifies Fenretinide as a GATA1-targeting agent that induces cytotoxicity in M6 and M7 AML cells by causing GATA1 loss and overcomes chemotherapeutic resistance.

bioRxiv · Jan 19, 2025 · PreprintCancer Biology